Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation

References

1. Falkeborn M, Schairer C, Naessen T, Persson I. Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol2000;53:832–7.10.1016/S0895-4356(00)00187-6Search in Google Scholar

2. Wouters MG, Moorrees MT, Van der Mooren MJ, Blom HJ, Boers GH, Schellekens LA, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest1995;25:801–5.10.1111/j.1365-2362.1995.tb01687.xSearch in Google Scholar

3. Hak AE, Polderman KH, Westerdorp IC, Jacobs C, Hofman A, Witteman JC, et al. Increased plasma homocysteine after menopause. Atherosclerosis2000;149:163–8.10.1016/S0021-9150(99)00321-4Search in Google Scholar

4. Morris M, Jacques P, Selhub J, Rosenberg I. Total homocysteine and estrogen status indicators in the Third National Health and Nutritional Examination Survey. Am J Epidemiol2000;152:140–8.10.1093/aje/152.2.140Search in Google Scholar

5. Van Baal WM, Smolders RG, Van der Mooren MJ, Teerlink T, Kenemans P. Hormone replacement therapy and plasma homocysteine levels. Obstet Gynecol1999;94:485–91.10.1097/00006250-199910000-00001Search in Google Scholar

6. Bernabei VM, Phillips TM, Hsia J. Plasma homocysteine in women taking hormone replacement therapy: the postmenopausal estrogen/progestin interventions (PEPI) trial. J Womens Health Gend Based Med1999;8:1167–72.10.1089/jwh.1.1999.8.1167Search in Google Scholar

7. Berger PB, Herrmann RR, Dumesic DA. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women. Mayo Clin Proc2000;75:18–23.10.4065/75.1.18Search in Google Scholar

8. Evio S, Tiitinen A, Turpeinen U, Ylikorkala O. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels. Fertil Steril2000;74:1080–3.10.1016/S0015-0282(00)01623-XSearch in Google Scholar

9. Ventura P, Cagnacci A, Malmusi S, Panini R, Baldassarri F, Arangino S, et al. Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. Menopause2001;8:252–8.10.1097/00042192-200107000-00006Search in Google Scholar PubMed

10. Chiantera V, Sarti CD, Fornaio F, Farzati A, De Franciscis P, Sepe E, et al. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels. Menopause2003;10:286–91.10.1097/01.GME.0000054762.94658.B4Search in Google Scholar PubMed

11. Smolders RG, Van der Mooren MJ, Teerlink T, Merkus JM, Kroeks MV, Franke HR, et al. A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels. Fertil Steril2003;79:261–7.10.1016/S0015-0282(02)04661-7Search in Google Scholar

12. Lacut K, Oger E, Abalain JK, Moineau MP, Mottier D, SARAH investigators. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial. Atherosclerosis2004;174:173–80.10.1016/j.atherosclerosis.2004.01.021Search in Google Scholar

13. Ghezzi F, Buttarelli M, Cromi A, Raio L, Cedars M, Bolis P. Plasma homocysteine levels after hormone therapy with and without folic acid supplementation: a randomized study. Fertil Steril2004;82:746–8.10.1016/j.fertnstert.2004.01.046Search in Google Scholar

14. Smolders RG, de Meer K, Kenemans P, Teerlink T, Jakobs C, Van der Mooren MJ. Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal women. Eur J Obstet Gynecol Reprod Biol2004;117:55–9.10.1016/j.ejogrb.2003.10.033Search in Google Scholar

15. Dimitrova KR, DeGroot K, Myers AK, Kim YD. Estrogen and homocysteine. Cardiovasc Res2002;53:577–88.10.1016/S0008-6363(01)00462-XSearch in Google Scholar

16. Reimann M, Vafeiadou K, Hall WL, Dierkes J, Nilsson M, Dahlman-Wright K, et al. Evidence for associations between common polymorphisms of estrogen receptor beta gene with homocysteine and nitric oxide. Climacteric2006;9:215–23.10.1080/13697130600733758Search in Google Scholar

17. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in the elderly. J Am Med Assoc1993;270:2693–8.10.1001/jama.270.22.2693Search in Google Scholar

18. Van Der Gried R, Biesma DH, Haas FJ, Faber JA, Duran M, Meuwissen OJ, et al. The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations. J Intern Med2000;248:223–9.10.1046/j.1365-2796.2000.00726.xSearch in Google Scholar

19. Masse PG, Dosy J, Cole DE, Evrovski J, Mahuren JD, Coburn SP. Elevation of plasma homocysteine in natural menopause cannot be explained by a lack of vitamin coenzyme availability: relevance to the risk of cardiovascular disease. J Nutr Health Aging2005;9:59–64.Search in Google Scholar

20. Toprak A, Erenus M, Ilhan AH, Haklar G, Fak AS, Oktay A. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level. Climacteric2005;8:279–86.10.1080/13697130500191040Search in Google Scholar

21. Saez G, Thornalley PJ, Hill HA, Herms R, Bannister JV. The production of free radicals during the autooxidation of cysteine and their effect on isolated rat hepatocytes. Biochim Biophys Acta1982;719:24–31.10.1016/0304-4165(82)90302-6Search in Google Scholar

22. Hellsten Y, Svensson M, Sjodin B, Smith S, Christensen A, Richter EA, et al. Allantoin formation and urate and glutathione exchange in human muscle during submaximal exercise. Free Radical Biol Med2001;31:1313–22.10.1016/S0891-5849(01)00631-1Search in Google Scholar

23. Ueland PM, Mansoor MA, Guttormsen AB. Reduced, oxidised and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiols status – a possible element of the extracellular antioxidant defence system. J Nutr1996;126:1281S–4S.10.1093/jn/126.suppl_4.1281SSearch in Google Scholar

24. Scott JM. Homocysteine and cardiovascular risk. Am J Clin Nutr2000;72:333–4.10.1093/ajcn/72.2.333Search in Google Scholar

25. Olszewski AJ, McCully KS. Homocysteine content of lipoproteins in hypercholesterolaemia. Atherosclerosis1991;88:61–8.10.1016/0021-9150(91)90257-4Search in Google Scholar

26. Earnest CP, Wood KA, Church TS. Complex multivitamin supplementation improves homocysteine and resistance to LDL-C oxidation. J Am Coll Nutr2003;22:400–7.10.1080/07315724.2003.10719323Search in Google Scholar

27. Villa P, Perri C, Suriano R, Cucinelli F, Panunzi S, Mele C, et al. L-Folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism. J Clin Endocrinol Metab2005;90:4622–9.10.1210/jc.2004-1954Search in Google Scholar

28. De Leo V, La Marca A, Morgante G, Ciani F, Zammarchi E, Setacci C. Low dose folic acid supplementation reduces plasma levels of the cardiovascular risk factor homocysteine in postmenopausal women. Am J Obstet Gynecol2000;183:945–7.10.1067/mob.2000.106345Search in Google Scholar

29. Van der Griend R, Haas FJ, Biesma DH, Duran M, Menwissen OJ, Banga JD. Combination of low dose folic acid and pyridoxine for treatment of hyperhomocysteinemia in patients with premature arterial disease and their relatives. Atherosclerosis1999;143:177–83.10.1016/S0021-9150(98)00273-1Search in Google Scholar

30. McCarty MF. Increased homocysteine associated with smoking, chronic inflammation, and ageing may reflect acute phase induction of pyridoxal phosphatase activity. Med Hypotheses2000;55:289–93.10.1054/mehy.1999.1032Search in Google Scholar PubMed

31. Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab1998;83:550–3.10.1210/jcem.83.2.4574Search in Google Scholar PubMed

32. McCarty MF. Insulin secretion a potential determinant of homocysteine levels. Med Hypotheses2000;55:454–5.10.1054/mehy.1999.1008Search in Google Scholar

33. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome. Diabetes Care2001;24:1403–10.10.2337/diacare.24.8.1403Search in Google Scholar

34. Sheu WH, Lee WJ, Chen YD. Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. Am J Hypertens2001;13:14–20.10.1016/S0895-7061(99)00138-7Search in Google Scholar

35. Schachter M, Raziel A, Friedler S, Strassburger D, Bern O, Ron-El R. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod2003;18:721–7.10.1093/humrep/deg190Search in Google Scholar

36. Dicker-Brown A, Fonseca VA, Fink LM, Kem PA. The effect of glucose and insulin on the activity of enzymes in homocysteine metabolism. Diabetes1999;48(Suppl 1):A135.Search in Google Scholar

37. Meigs JB, Jacques PF, Selhub J, Sunger DE, Nathan DM, Rifai N, et al.; Framingham Offspring Study. Fasting plasma homocysteine levels in the insulin resistance syndrome. Diabetes Care2001;24:1403–10.10.2337/diacare.24.8.1403Search in Google Scholar

38. Gillum R. Distribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American men: the Third National Health and Nutrition Examination Survey. Nutrition J2003;2:6–13.10.1186/1475-2891-2-6Search in Google Scholar

39. Abbasi F, Facchini F, Humphreys MH, Reaven GM. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin mediated glucose disposal. Atherosclerosis1999;146:175–8.10.1016/S0021-9150(99)00132-XSearch in Google Scholar

40. Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab2001;86:719–23.10.1210/jc.86.2.719Search in Google Scholar

41. Setola E, Monti LD, Galluccio E, Pallosi A, Fracasso G, Paroni R, et al. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol2004;151:483–9.10.1530/eje.0.1510483Search in Google Scholar PubMed

42. Stehouwer CD, Van Guldener C. Does homocysteine cause hypertension? Clin Chem Lab Med2003;41:1408–11.10.1515/CCLM.2003.216Search in Google Scholar PubMed

43. Woo KS, Chook P, Chan LL, Cheung AS, Fung WH, Qiao M, et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med2002;112:535–9.10.1016/S0002-9343(02)01075-6Search in Google Scholar

44. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest2006;91:308–18.10.1172/JCI116187Search in Google Scholar PubMed PubMed Central

45. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest1986;77:1370–6.10.1172/JCI112442Search in Google Scholar PubMed PubMed Central

46. Rasmussen LB, Ovesen L, Bulow I, Knudsen N, Laurberg P, Perrild H. Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women. Am J Clin Nutr2000;72:1156–63.10.1093/ajcn/72.5.1156Search in Google Scholar PubMed

47. Paradisi G, Cucinelli F, Mele MC, Barini A, Lanzone A, Caruso A. Endothelial function in post-menopausal women: effect of folic acid supplementation. Human Reprod2004;19:1031–5.10.1093/humrep/deh189Search in Google Scholar PubMed

48. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation2002;105:22–6.10.1161/hc0102.101388Search in Google Scholar PubMed

49. Stroes ES, van Faassen EE, Yo M, Martasek P, Boer P, Govers R, et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res2000;86:1129–34.10.1161/01.RES.86.11.1129Search in Google Scholar

50. Doshi SN, McDowell IF, Moat SJ, Lang D, Newcombe RG, Kredan MB, et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol2001;21:1196–202.10.1161/hq0701.092000Search in Google Scholar PubMed

51. Ziakka S, Rammos G, Kountouris S, Doulgerakis C, Karakasis P, Kourvelou C, et al. The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis. Int Urol Nephrol2001;33:559–62.10.1023/A:1019559328424Search in Google Scholar